[HTML][HTML] The use of misoprostol in termination of second-trimester pregnancy
CJ Lin, SC Chien, CP Chen - Taiwanese Journal of Obstetrics and …, 2011 - Elsevier
Misoprostol, a synthetic prostaglandin E1 analog, is initially used to prevent peptic ulcer. The
initial US Food and Drug Administration-approved indication in the product labeling is the …
initial US Food and Drug Administration-approved indication in the product labeling is the …
Use of misoprostol in obstetrics and gynecology
J Song - Obstetrical & Gynecological Survey, 2000 - journals.lww.com
Misoprostol is prostaglandin E 1 analogous and marketed for prevention and treatment of
peptic ulcer disease. However, it has been used widely in obstetrics and gynecology …
peptic ulcer disease. However, it has been used widely in obstetrics and gynecology …
Misoprostol for termination of second trimester pregnancy in a scarred uterus.
AG Shammas, MD Momani - Saudi medical journal, 2006 - europepmc.org
Objective To investigate whether Misoprostol for mid-trimester pregnancy interruption in
women with a scarred uterus has any adverse effects compared with those without a scar …
women with a scarred uterus has any adverse effects compared with those without a scar …
[PDF][PDF] Misoprostol for second trimester termination of pregnancies with prior low transverse cesarean section
S Pongsatha, T Tongsong - International Journal of Gynecology & …, 2003 - w1.med.cmu.ac.th
Recently, misoprostol has become a major method used for pregnancy interruption in our
institute because of its low cost, effectiveness and drug stability. However, although …
institute because of its low cost, effectiveness and drug stability. However, although …
Outcomes of second-trimester pregnancy terminations with misoprostol: comparing 2 regimens
RK Edwards, SM Sims - American journal of obstetrics and gynecology, 2005 - Elsevier
OBJECTIVE: The purpose of this study was compare outcomes of second-trimester
pregnancy terminations with misoprostol between our previous low-(200 μg every 12 h) and …
pregnancy terminations with misoprostol between our previous low-(200 μg every 12 h) and …
[HTML][HTML] Uses of misoprostol in obstetrics and gynecology
R Allen, BM O'Brien - Reviews in obstetrics and gynecology, 2009 - ncbi.nlm.nih.gov
Misoprostol is a synthetic prostaglandin E 1 analogue that is used off-label for a variety of
indications in the practice of obstetrics and gynecology, including medication abortion …
indications in the practice of obstetrics and gynecology, including medication abortion …
Vaginal misoprostol in termination of second trimester pregnancy
Y Herabutya, B Chanrachakul… - Journal of Obstetrics …, 2000 - Wiley Online Library
Objective: To study the effectiveness and complications of 600 μg of intravaginal misoprostol
for terminating second trimester pregnancies. Study Design: One hundred and seventy‐two …
for terminating second trimester pregnancies. Study Design: One hundred and seventy‐two …
Induction of labor with vaginal misoprostol for second trimester termination of pregnancy in the scarred uterus
Y Herabutya, B Chanarachakul… - International journal of …, 2003 - Elsevier
Objectives: To assess the safety of vaginal misoprostol for second trimester pregnancy
termination in patients with a history of cesarean section. Methods: A consecutive series of …
termination in patients with a history of cesarean section. Methods: A consecutive series of …
[PDF][PDF] Outcomes of pregnancy termination by misoprostol at 14-32 weeks of gestation: a 10-year-experience
S Pongsatha, T Tongsong - Journal of the Medical Association of …, 2011 - w1.med.cmu.ac.th
Objective: To review outcomes of pregnancy termination between 14-32 weeks of gestation
based on a10-year-experience of misoprostol use at Maharaj Nakorn Chiang Mai Hospital …
based on a10-year-experience of misoprostol use at Maharaj Nakorn Chiang Mai Hospital …
Use of misoprostol for the termination of second trimester pregnancies
A Elsheikh, A Antsaklis, S Mesogitis… - Archives of gynecology …, 2001 - Springer
Surgical termination of pregnancy is of high risk for the woman's health and safe medical
ways are required. The use of prostaglandins may substantially reduce this risk. The efficacy …
ways are required. The use of prostaglandins may substantially reduce this risk. The efficacy …